Autolus director receives option and RSU grants

Autolus Therapeutics plc director Linda Bain received new equity awards as part of her compensation.

Rhea-AI Filing Summary

Autolus Therapeutics plc director Linda Bain received new equity awards as part of her compensation. She was granted a share option covering 47,500 American Depositary Shares with an exercise price of $1.61 per share, expiring on June 29, 2036. These options vest in twelve equal monthly installments starting on July 29, 2026.

She also received 31,667 restricted share units, each representing a contingent right to one American Depositary Share. The RSUs vest in a single installment on June 29, 2027. Each American Depositary Share is convertible at any time into one ordinary share, providing future potential ownership if the awards vest and, for options, are exercised.

Insider Trade Summary

Grant/Award: 79,167 shares

Grant/Award 2 txns

Insider Bain Linda

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Share Units	31,667	$0.00	$0.00
Grant/Award	Share Option (Right to Buy)	47,500	$0.00	$0.00

Holdings After Transaction: Restricted Share Units — 31,667 contracts (Direct); Share Option (Right to Buy) — 47,500 contracts (Direct)

Footnotes (3)

1. F1. Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's American Depositary Shares. Each American Depositary Share is convertible at any time at the option of the Reporting Person into one Ordinary Share.
2. F2. The RSUs vest in one installment on June 29, 2027.
3. F3. Share options vest in twelve equal monthly installments commencing on July 29, 2026.

Key Figures

Stock options granted: 47,500 options Option exercise price: $1.61 per share Option expiration: June 29, 2036 +4 more

7 metrics

Stock options granted 47,500 options Grant of share options on June 29, 2026

Option exercise price $1.61 per share Exercise price for granted share options

Option expiration June 29, 2036 Expiration date of share options

RSUs granted 31,667 RSUs Restricted share units granted on June 29, 2026

RSU vesting date June 29, 2027 Single-installment vesting date for RSUs

Options vesting schedule 12 monthly installments Commencing July 29, 2026

Underlying security American Depositary Shares Underlying for both options and RSUs

Key Terms

Restricted Share Units, Share Option (Right to Buy, American Depositary Shares, exercise price

4 terms

Restricted Share Units financial

"The RSUs vest in one installment on June 29, 2027."

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

Share Option (Right to Buy financial

"Share Option (Right to Buy) granted covering 47,500 ADS."

American Depositary Shares financial

"Each restricted stock unit represents a contingent right to receive one share of the Issuer's American Depositary Shares."

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

exercise price financial

"Share options have an exercise price of $1.61 per share."

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did Autolus (AUTL) director Linda Bain receive?

Linda Bain received a share option for 47,500 American Depositary Shares and 31,667 restricted share units. These awards are compensation-related grants, not open-market purchases or sales, and give her potential future ownership if vesting and exercise conditions are met.

When do Linda Bain’s new Autolus (AUTL) stock options vest?

The 47,500 share options granted to Linda Bain vest in twelve equal monthly installments beginning on July 29, 2026. This monthly vesting schedule spreads the option entitlement over one year, aligning continued service with the gradual delivery of exercisable options.

When do Linda Bain’s Autolus (AUTL) restricted share units vest?

Linda Bain’s 31,667 restricted share units vest in one installment on June 29, 2027. Once vested, each restricted share unit converts into one American Depositary Share, giving her direct equity exposure without an exercise price, subject to any applicable settlement terms.

What is the exercise price of Linda Bain’s Autolus (AUTL) stock options?

The granted share options have an exercise price of $1.61 per American Depositary Share. This means Bain must pay $1.61 per share to exercise vested options before their expiration on June 29, 2036, if she chooses to convert them into actual shares.

How do Autolus (AUTL) RSUs and options granted to Linda Bain relate to shares?

Each restricted share unit represents a contingent right to receive one American Depositary Share. Each American Depositary Share is convertible into one ordinary share. The stock options similarly relate to American Depositary Shares, which can later convert into ordinary shares upon exercise.

Are Linda Bain’s Autolus (AUTL) equity grants open-market transactions?

No. The filing identifies both transactions with code A as grants or awards. They are compensation-related equity awards, not open-market buys or sells, and therefore do not reflect discretionary trading decisions in the company’s stock by the director.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/01/2026 - 04:08 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bain Linda

(Last) (First) (Middle)

THE MEDIAWORKS, WHITE CITY

C/O AUTOLUS THERAPEUTICS PLC

(Street)

LONDON W12 7FP

(City) (State) (Zip)

UNITED KINGDOM

(Country)

2. Issuer Name and Ticker or Trading Symbol
Autolus Therapeutics plc [ AUTL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Share Units	(1)	06/29/2026		A		31,667		(2)	(2)	American Depositary Shares	31,667	$0	31,667	D
Share Option (Right to Buy)	$1.61	06/29/2026		A		47,500		(3)	06/29/2036	American Depositary Shares	47,500	$0	47,500	D

Explanation of Responses:

1. Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's American Depositary Shares. Each American Depositary Share is convertible at any time at the option of the Reporting Person into one Ordinary Share.

2. The RSUs vest in one installment on June 29, 2027.

3. Share options vest in twelve equal monthly installments commencing on July 29, 2026.

	/s/ Linda Bain	07/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)